TAU researchers develop mRNA-based vaccine against deadly bacterium
Researchers from Tel Aviv University (TAU) and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium. In the groundbreaking study, the researchers tested the vaccine’s resistance to the virulent pathogen that causes the disease and… Read More